Pay in 4 interest-free payments of $7.39 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Adverse Reactions (6.1).] Maintenance of JANUVIA During Initiation and Titration of Insulin Glargine A total of 746 patients with type 2 diabetes (mean baseline HbA1C 8.8%, disease duration 10.8 years) participated in a 30-week, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of continuing JANUVIA during the initiation and uptitration of insulin glargine
An independent affiliate publisher produced this content and may earn a commission if readers enroll through links here, at no added cost to you
Book Now Achieve a deeper tan, support sun protection, and boost confidence with Melanotan II 10 mg peptide therapy
Access this article Similar content being viewed by others Data Availability No datasets were generated or analysed during the current study
US$ 25.77
US$ 20.59
US$ 28.57
